Kefurox 1500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kefurox 1500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial

eurocept b.v. - cefuroxime sodium 1500 mg - powder for suspension for infusion; powder for suspension for injection; powder for solution for injection/infusion - cefuroxime

Kefurox 750 mg inj./inf. sol. (pwdr.) i.m./i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kefurox 750 mg inj./inf. sol. (pwdr.) i.m./i.v. vial

eurocept b.v. - cefuroxime sodium - eq. cefuroxime 750 mg - powder for solution for injection/infusion - cefuroxime

Thiotepa Riemser European Union - English - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastic agents - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients